UFP Technologies (FRA:UFP) ROCE %: 15.96% (As of Mar. 2026)

What is UFP Technologies ROCE %?

UFP Technologies FRA:UFP -0.55% 96 ROCE % is 15.96% as of Mar. 2026. GuruFocus rates FRA:UFP with a GF Score™ of 96/100 and a GF Value™ of €227.62 (Fairly Valued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. UFP Technologies's annualized ROCE % for the quarter that ended in Mar. 2026 was 15.96%.

UFP Technologies (FRA:UFP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

UFP Technologies ROCE % Related Terms

UFP Technologies ROCE % Historical Data

* Premium members only.

The historical data trend for UFP Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UFP Technologies ROCE % Chart

UFP Technologies Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

9.04

18.52

16.98

18.33

15.41

UFP Technologies Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															16.30	16.67	16.37	14.94	15.96

96GF Score

UFP Technologies Inc FRA:UFP

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

UFP Technologies ROCE % Calculation

UFP Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	78.839	/	( ( (600.69 - 72.862)	+	(559.436 - 63.932) )	/ 2 )
	=	78.839	/	( (527.828	+	495.504)	/ 2 )
	=	78.839	/	511.666
	=	15.41 %

UFP Technologies's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	80.772	/	( ( (559.436 - 63.932)	+	(583.602 - 66.616) )	/ 2 )
	=	80.772	/	( ( 495.504	+	516.986 )	/ 2 )
	=	80.772	/	506.245
	=	15.96 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 15.96% mean?

UFP Technologies (FRA:UFP) has a ROCE % of 15.96% as of Mar. 2026.

Is UFP Technologies' ROCE % too high?

UFP Technologies' current ROCE % is 15.96%. The Medical Devices & Instruments industry median ROCE % is 2.30. UFP Technologies' value of 15.96% is 595.4% above this industry median. Overall, UFP Technologies has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does UFP Technologies' ROCE % compare to NEOG and ALMR?

UFP Technologies' ROCE % of 15.96% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.30. UFP Technologies' value of 15.96% is 595.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.30, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. UFP Technologies's current ROCE % of 15.96% is 595.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UFP Technologies's current ROCE % is 15.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is UFP Technologies stock overvalued right now?

Based on GuruFocus' analysis, UFP Technologies (FRA:UFP) is currently considered Fairly Valued. The stock's GF Value™ is €227.62, compared to a current price of €217.40 — trading 4.5% below its estimated fair value. The current ROCE % is 15.96% and 595.4% above the Medical Devices & Instruments industry median of 2.30. UFP Technologies' overall GF Score™ is 96/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For UFP Technologies (FRA:UFP), the current ROCE % is 15.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is UFP Technologies (FRA:UFP) Overvalued in 2026?

Based on GuruFocus' analysis, UFP Technologies stock appears to be undervalued. The current stock price of €217.40 is trading 4.5% below its estimated GF Value™ of €227.62. GuruFocus considers UFP Technologies to be Fairly Valued.

Key valuation signals for FRA:UFP:

ROCE %: 15.96%
GF Value™: €227.62 vs. price of €217.40 (4.5% below fair value)
GF Score™: 96/100 with 2 warning signs
Industry Position: 595.4% above the Medical Devices & Instruments median

No single metric tells the full story. See the FRA:UFP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

UFP Technologies Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies NEOG ALMR NVCR BFLY TMDX AXGN IART ATEC ESTA AHCO ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Other Exchanges UFPT:USA

Address 100 Hale Street, Newburyport, MA, USA, 01950-3504

Website https://www.ufpt.com

UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

96GF Score

Get the complete analysis for FRA:UFP

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€217.40

Price

€227.62

GF Value

View FRA:UFP Analysis

See ROCE % data for all stocks →